Related references
Note: Only part of the references are listed.Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis
Jean-Guy Boiteau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345
Christian Gege
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
RORγ antagonists and inverse agonists: a patent review
Sarah M. Bronner et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparatore-controlled VOYAGE 2 trial
Kristian Reich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A convenient one-pot synthesis of boroxoles from diboronic acid
Guillaume Lafitte et al.
TETRAHEDRON LETTERS (2017)
Discovery of a series of 8-(2,3-dihydro-1,4-benzoxazin-4-ylmethyl)-2-morpholino-4-oxo-chromene-6-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours
Bernard Barlaam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Recent progress on nuclear receptor RORγ modulators
Patrick Cyr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
Gilles Ouvry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo
Daliya Banerjee et al.
IMMUNOLOGY (2016)
Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis
Xiaohua Xue et al.
SCIENTIFIC REPORTS (2016)
Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways
Timo Buhl et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors
Jeremy Green et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Regioselective synthesis of 2H-indazoles through Ga/Al- and Al-mediated direct alkylation reactions of indazoles
Mei-Huey Lin et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Steric and Electronic Requirements in the Synthesis of 2,3-Dihydro-4(1H)-quinolinones by the Tandem Michael-SNAr Reaction
Richard A. Bunce et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2015)
3-Alkoxy-pyrrolo[1,2-b]pyrazolines as Selective Androgen Receptor Modulators with Ideal Physicochemical Properties for Transdermal Administration
Thomas Ullrich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
REV-ERB and ROR nuclear receptors as drug targets
Douglas J. Kojetin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
IL-17/Th17 Pathway Is Activated in Acne Lesions
Hanna-Leena Kelhala et al.
PLOS ONE (2014)
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc
Benjamin P. Fauber et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Novel preparation of chiral α-amino acids using the Mitsunobu-Tsunoda reaction
Anais F. M. Noisier et al.
CHEMICAL COMMUNICATIONS (2013)
The IL23R A/GIn381 Allele Promotes IL-23 Unresponsiveness in Human Memory T-Helper 17 Cells and Impairs Th17 Responses in Psoriasis Patients
Paola Di Meglio et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Tosylhydrazones: New Uses for Classic Reagents in Palladium-Catalyzed Cross-Coupling and Metal-Free Reactions
Jose Barluenga et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
Robert J. Young et al.
DRUG DISCOVERY TODAY (2011)
IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
Heather L. Rizzo et al.
JOURNAL OF IMMUNOLOGY (2011)
Epidermal CCR6+ γδ T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis
Tomotaka Mabuchi et al.
JOURNAL OF IMMUNOLOGY (2011)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
Thomas Ryckmans et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
CCR6 is required for IL-23-induced psoriasis-like inflammation in mice
Michael N. Hedrick et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2009)
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Chizuko Koga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Copper-mediated N-cyclopropylation of azoles, amides, and sulfonamides by cyclopropylboronic acid
Sebastien Benard et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
Prediction of drug solubility by the general solubility equation (GSE)
YQ Ran et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)